Gene therapy company picks North Carolina for 200-job manufacturing facility

Gene therapy company Audentes Therapeutics, which last month completed a $3 billion buyout by Astellas Pharma, picked a North Carolina site over competing locations in California, Massachusetts and Colorado for a 209-job manufacturing facility, the company said Tuesday. The expected $109.4 million investment at the site in Sanford, North Carolina, comes in exchange for a "job development investment grant" worth up to $3.7 million that was approved by North Carolina state officials. Additionally,…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news